Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
9 Meters Biopharma Inc (EM)
NMTRQ
Healthcare
Industrials
Biotechnology
Conglomerates
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders in North America. Its lead product candidate is Vurolenatide, a long-acting injectable glucagon-like-peptide-1 that is in Phase 3 clinical trial to treat short bowel syndrome. The company is...
developing NM-136, a humanized monoclonal antibody for the treatment of obesity and obesity-related disorders; NM-102, a small molecule peptide to prevent antigens from trafficking into systemic circulation; and NM-003, a proprietary long-acting glucagon-like peptide-2 receptor agonist for prevention of acute graft versus host disease. Its partnered product is Larazotide, an 8-amino acid peptide, which is in Phase 2 clinical trial for treatment of multi-system inflammatory syndrome. The company has licensing agreements with Amunix, MHS Care Innovation LLC, Alba Therapeutics Corporation, and EB...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (EXPM:NMTRQ)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(657)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 27, 2022 9:19am
NMTR ....NR after yesrdys close...up a little but....
There's lots of shs O/S It's getting "pumped" Not my style No position
(0)
•••
FrugalNorwegian
X
Post by
FrugalNorwegian
on May 07, 2021 5:20pm
new site with deep DD on NMTR
New site with Deep DD on NMTR: FrugalNorwegian.com - All information on 1 page - Catalyst countdown timer - Several videos to watch - Provides a high level summary, and goes deep into the
...more
(126)
•••
Bagofhammers
X
Post by
Bagofhammers
on Jan 29, 2021 6:39pm
Double$
Enjoy doubling my original investment.
(126)
•••
Bagofhammers
X
Post by
Bagofhammers
on Jan 05, 2021 7:24pm
Whats Going On Here?
Is it the Dec 21 PR on the COV19 evaluation of respiratory complications? Killing it afterhours as well.
(0)
•••
CPPInvestments
X
Post by
CPPInvestments
on Dec 15, 2020 5:45pm
LARGE INSIDER BUYING - PH3 DRUG
ADDED
(0)
•••
CPPInvestments
X
Post by
CPPInvestments
on Dec 11, 2020 11:20am
9 Meters - Phase 3 drug / NMTR
Very large (recent) insider/fund buying
(126)
•••
Bagofhammers
X
Comment by
Bagofhammers
on Nov 17, 2020 2:28pm
RE:big volume
Business Updates. clincial data results 1b/2A POC by year end
(5)
•••
kalareta
X
Post by
kalareta
on Nov 13, 2020 1:34pm
big volume
Anybody knows why volume increased? Is something coming up?
(5)
•••
kalareta
X
Comment by
kalareta
on Oct 05, 2020 8:26am
RE:RE:Trending Upwards
Good then we will load more.
(4)
•••
Shortandcollect
X
Comment by
Shortandcollect
on Oct 04, 2020 9:06pm
RE:Trending Upwards
Going down to 50 cents Bago. Shorting again.
(5)
•••
kalareta
X
Comment by
kalareta
on Oct 04, 2020 1:44pm
RE:Trending Upwards
I hope so. Couple years ago was 35 dol. per share.
(126)
•••
Bagofhammers
X
Post by
Bagofhammers
on Oct 04, 2020 11:54am
Trending Upwards
This has been pegged at @ $10 s/p. The trend is indicating as such over the long term. Currently 150 patents worldwide. https://9meters.com
(126)
•••
Bagofhammers
X
Post by
Bagofhammers
on Aug 19, 2020 7:31pm
Up 29.85% even better
EOM
(126)
•••
Bagofhammers
X
Post by
Bagofhammers
on Aug 18, 2020 7:48pm
Up 16.5% not bad
EOM
(94)
•••
Troy23
X
Comment by
Troy23
on May 13, 2020 10:21am
RE:RE:First Analyst Day tomorrow
Price targets are set for a year time... however, it is never guaranteed...sometimes targets can be adjusted after a few months if the price is higher than the target. same thing if the price goes
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Sorrento Resources Announces Drilling Contract and Receives Permit to Drill Bottom Brook Project
Podcasts